Reuters logo
4 个月前
Dialysis chain DaVita wins approval to buy Renal Ventures with conditions
2017年3月28日 / 下午5点17分 / 4 个月前

Dialysis chain DaVita wins approval to buy Renal Ventures with conditions

1 分钟阅读

WASHINGTON, March 28 (Reuters) - Kidney dialysis company DaVita, Inc has won antitrust approval to buy rival Renal Ventures Management LLC on condition that it sell five clinics, the Federal Trade Commission said on Tuesday.

The clinics to be divested are in New Jersey and Texas, the agency said. (Reporting by Diane Bartz; Editing by Chizu Nomiyama)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below